Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06273436 · ClinicalTrials.gov registry record · NA
Healing, Equity, Advocacy and Respect for Mamas
A NA study of Postpartum Complication, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 2,894
- Enrollment target
- 1
- Study location
NCT06273436 is a NA study of Postpartum Complication that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 2,894 participants, above the 1,845-participant average among 3 other Postpartum Complication trials with a reported enrollment target (57% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06273436, a NA study of Postpartum Complication, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,894 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant health disparities.
Conditions Studied
Interventions
- OTHER H.E.A.R. for Mamas
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,894 participants |
| Start Date | 2024-05-28 |
| Est. Completion | 2030-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06273436
The ClinicalTrials.gov registry entry for NCT06273436 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,894 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,845-participant average among 3 other Postpartum Complication trials with a reported enrollment target (57% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postpartum Complication appearing as the primary indexed condition, and to 1 intervention - of which H.E.A.R. for Mamas is the first listed.
NCT06273436 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06273436 about?
NCT06273436 is a clinical study titled "Healing, Equity, Advocacy and Respect for Mamas". The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant healt...
What is the current status of trial NCT06273436?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,894 participants. The study started on 2024-05-28. Estimated completion is 2030-03-30.
What conditions does trial NCT06273436 study?
This clinical trial studies the following conditions: Postpartum Complication.
What interventions are being tested in trial NCT06273436?
The interventions under investigation include: H.E.A.R. for Mamas (OTHER).
Who is sponsoring clinical trial NCT06273436?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06273436 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.